INNT
TOTAL INVALIDATION PROCESSED BY THE IB
01/09/2022
Back to search
Official data from USPTO
MEDIGENE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
01/09/2022
Trademark type
Word
Nice classes
5
Filing date
04/27/2007
Registration date
03/17/2009
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/26/2021
Last transaction
02/26/2021
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
FRENCH, CURTIS
Law office
M60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
MediGene AG
Representatives
Adrienne L. White WRB-IP LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicines for humans and animalsexcept venous-therapeuticsmedicines for treating cardiovascular and vascular diseasesdermatological disorders and diseasesprecancerous diseasesbenign and malignant tumorsinfectious diseasesallergic and asthmatic diseasesneurodegenerative diseasesautoimmune diseasesdiseases of the respiratory tractgastrointestinal diseasesblood disordersaging-associated diseasesgenetic disordersmetabolic disordersmusculoskeletal disorders and eye diseasesvaccines for treating cardiovascular and vascular diseasesdermatological disorders and diseasesprecancerous diseasesbenign and malignant tumorsinfectious diseasesallergic and asthmatic diseasesneurodegenerative diseasesautoimmune diseasesdiseases of the respiratory tractgastrointestinal diseasesblood disordersaging-associated diseasesgenetic disordersmetabolic disordersmusculoskeletal disorders and eye diseases; serumsimmune serums for passive vaccination for treating infectious diseasesdiagnostic test kits comprising antibodiesantibody fragmentsserumssoluble monoclonal T-cell receptorspeptidespeptide-analoguesenzymesliposomesdyesradioactively labeled substancesfor the purpose of testingdiagnosing and monitoring cardiovascular and vascular diseasesdermatological disorders and diseasesprecancerous diseasesbenign and malignant tumorsinfectious diseasesallergic and asthmatic diseasesneurodegenerative diseasesautoimmune diseasesdiseases of the respiratory tractgastrointestinal diseasesblood disordersaging-associated diseasesgenetic disordersmetabolic disordersmusculoskeletal disorders and eye diseases; proteinsproteinconjugatespeptidesenzymes and enzyme-preparationsantibodiesT-cell-proteinsattenuated virusesvirus-like particlesliposomesherbal extractscomponents of low molecular weightall for use as medicinesvaccines and parts of medical diagnostic test kits for treatingtestingdiagnosing and monitoring all diseases mentioned above
Publications
History of USPTO decisions and trademark events.
44 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
12/01/2021
INPC
INVALIDATION PROCESSED
12/01/2021
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
10/26/2021
C71T
CANCELLED SECTION 71
02/26/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/23/2018
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
03/17/2018
RNWL
INTERNATIONAL REGISTRATION RENEWED
05/11/2017
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
03/23/2015
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
03/23/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/23/2015
ES75
TEAS SECTION 71 & 15 RECEIVED
03/17/2015
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/12/2013
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/24/2009
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/01/2009
FIMP
FINAL DISPOSITION PROCESSED
07/01/2009
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/17/2009
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/27/2009
R.PR
REGISTERED-PRINCIPAL REGISTER
03/17/2009
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/12/2009
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/12/2009
PUBO
PUBLISHED FOR OPPOSITION
12/30/2008
NPUB
NOTICE OF PUBLICATION
12/10/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/25/2008
ALIE
ASSIGNED TO LIE
11/25/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/20/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/18/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/17/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/17/2008
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/17/2008
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/17/2008
CNRT
NON-FINAL ACTION MAILED
05/21/2008
CNRT
NON-FINAL ACTION WRITTEN
05/21/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/28/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/28/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/28/2008
RFNT
REFUSAL PROCESSED BY IB
11/16/2007
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/26/2007
RFRR
REFUSAL PROCESSED BY MPU
10/25/2007
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/25/2007
CNRT
NON-FINAL ACTION WRITTEN
10/24/2007
DOCK
ASSIGNED TO EXAMINER
10/12/2007
NWAP
NEW APPLICATION ENTERED
10/12/2007
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/11/2007
Continuous trademark protection
Get notified about every new filing that threatens MEDIGENE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.